Akiko Komori

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events

Masaru Miura, Tohru Kobayashi, Tetsuji Kaneko et al. · JAMA Pediatrics · 2018 · 148 citations · Full text

Medicine, Cardiology, Internal Medicine +17

The Follow-up Evaluation of Electrocardiogram and Arrhythmias in Children With Fluminant Myocarditis

Rie Ichikawa, Naokata Sumitomo, Akiko Komori et al. · Circulation Journal · 2011 · 45 citations · Full text

Medicine, Cardiology, Pediatrics +17

Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression

Taichi Kato, Masaru Miura, Tohru Kobayashi et al. · Journal of the American Heart Association · 2023 · 37 citations · Full text

Medicine, Cardiology, Internal Medicine +8

Effects of miglitol, an α-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats

Toshinao Goda, Kazuhito Suruga, Akiko Komori et al. · British Journal Of Nutrition · 2007 · 30 citations · Full text

Medicine, Endocrinology, Pharmacology +17